Capsaicin.
Research-backed compound with potential health benefits. Boosts metabolism slightly, can reduce appetite, and helps your body burn a bit more fat. Topically, it's used for nerve and joint pain.
Reviewed March 2026
- Category
- Compound
What Capsaicin is, and what it does.
- Does it work
- Maybe. The effects on weight loss are real but small. Think of it as a slight edge, not a primary driver. More compelling for pain when used in a cream.
- How much to take
- For metabolism, 100-150 mg of cayenne pepper extract (standardized for capsaicinoids), taken with meals. For topical pain, follow the cream's directions.
- Time to feel it
- Warmth turns up within about 20 to 30 minutes, and the appetite effect lands at that same meal. Changes in body composition run over weeks alongside how you eat and train.
- The first dose
- You might feel a warming sensation and slightly less hunger at your next meal. That's about it.
- With regular use
- Over weeks, you might see a very modest change on the scale if your diet and exercise are on point. The appetite suppression is the most consistent effect.
- How well tolerated
- Generally well tolerated. The main issue is gut irritation. Don't take it on an empty stomach. If you're on blood pressure meds, talk to your doctor first.
- How it feels
- A gentle internal warmth. Not a stimulant buzz. You'll feel it more in your stomach than your head. It basically makes you feel 'spicy'.
- The overlooked benefit
- Taking it with a meal that contains fat raises how much you absorb, and it blunts the burn at the same time, so the fat is doing two jobs at once.
2 to 6mg a day is where Capsaicin works.
Source: Whiting et al. 2012 Appetite meta-analysis (9 RCTs); Ludy et al. 2012 Chem Senses.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Capsaicin is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Short-term energy expenditure and fat oxidationMeta-analysis
- Appetite and food intake at the following mealRandomised trial
- Local sensory nerve signalling when applied to skinRandomised trial
- Body composition alongside diet and trainingMeta-analysis
- Skin blood flow at the site of applicationRandomised trial
Questions people ask about Capsaicin.
- Will this make me lose weight?
- It helps, but very slightly. It's a small boost, not a magic pill. Diet and exercise do 99% of the work.
- Is it just like eating spicy food?
- Basically, yes. A supplement just gives you a standardized dose without having to eat a ghost pepper.
- Is it safe to take every day?
- Yes, for most people. The body gets used to it, so the 'burn' feeling might fade over time.
- What's the difference between capsaicin and cayenne pepper extract?
- Capsaicin is the main active compound. Cayenne pepper extract is the whole-food source, standardized to contain a specific amount of capsaicin.
- Can I just take the cream orally?
- No. Absolutely not. Topical creams are for skin only and can be toxic if ingested.
- Does it interact with medications?
- Yes. Heads up: it can interact with blood thinners and some blood pressure medications. Check with your doctor.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Capsaicin is a lipophilic vanillamide with poor water solubility, so it partitions into dietary or added fat before it crosses the intestinal wall. A medium-chain triglyceride carrier gives the molecule a phase to sit in and keeps it dispersed in a capsule or an emulsion. This is absorption chemistry rather than a clinical outcome, and no combination trial is being described here.
Lecithin lowers interfacial tension and lets a lipophilic capsaicinoid disperse in a water-based liquid or a gummy matrix instead of separating out. The pairing is formulation convention, common wherever a hot-tasting oleoresin has to be kept uniform in a dose. It says nothing about how capsaicin behaves once absorbed.
Piperine and capsaicin are both agonists at sensory transient receptor potential channels on trigeminal and gut afferents, which is why both read as pungent warmth. Taken together the sensory signal adds up and the perceived heat of a dose rises. Piperine is also a well-described inhibitor of intestinal and hepatic metabolising enzymes, which is a separate reason the two are often formulated together.
Gingerols and shogaols activate the same vanilloid receptor family that capsaicin does, so the two pungent botanicals stack on the same sensory and gastric warmth signal. Formulators pair them for that reason in thermogenic blends. The additive part is receptor-level and mechanistic; it is not an outcome measured in a combination trial.
TRPV1 opened by capsaicin passes calcium as well as sodium, and the calcium that enters the nerve terminal is what triggers calcineurin-dependent desensitisation of the same channel. That is why repeated capsaicin exposure feels progressively less hot. This is channel biophysics measured in neurons and cell systems, not a claim that taking calcium with capsaicin changes anything a person would notice.
Capsaicin raises catecholamine release through TRPV1-linked sympathetic activation, and caffeine acts on adenosine receptors to push the same sympathetic tone and to blunt perceived effort. The two are routinely combined in pre-workout products for that overlap. What is described is the shared pathway; the pairing itself has not been isolated in the studies available here.
Catechins slow catecholamine breakdown at catechol-O-methyltransferase while capsaicin increases catecholamine output, so the two act on opposite ends of the same signal. Thermogenesis blends have used that pairing for years. Read it as mechanistic overlap rather than a measured combined effect.
Curcumin and capsaicin are both poorly water-soluble plant actives that need the same kind of fat or phospholipid vehicle to stay dispersed, so they travel together well in a softgel. Curcumin also has documented activity at sensory TRP channels adjacent to the one capsaicin opens. The connection is chemistry and formulation, not a clinical combination result.
Beta-alanine raises muscle carnosine and buffers intracellular acidity during high-intensity work, while acute capsaicin has been studied for perceived exertion and performance in the same kind of protocol. They act at different points, which is why they are stacked. No study here measured the pair together, so this stays at the low end of confidence.
Bicarbonate works extracellularly as a pH buffer during repeated high-intensity efforts; acute capsaicin has been examined for rating of perceived exertion in comparable sessions. The two do not share a target, which is the argument for combining them. Nothing in the available literature tested the combination.
Dietary nitrate raises nitric oxide availability and influences blood flow and oxygen cost of exercise, a different route from capsaicin's sensory-neuron activation. Pre-workout formulas often carry both. This is a formulation pairing with mechanistic separation, not a measured joint result.
Carnitine shuttles long-chain fatty acids into the mitochondrion, and capsaicin has been reported in animal work to shift the transcriptional signature of adipose energy metabolism. The two touch fat handling at different steps. No human combination data appears in the candidate set.
Nothing specific on file for Capsaicin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Capsaicin actually does.
Capsaicin is a selective agonist at TRPV1, a non-selective cation channel on sensory neurons; opening it lets sodium and calcium into the terminal and generates the warmth signal the compound is known for.
Calcium entering through the opened TRPV1 channel drives calcineurin-dependent desensitisation, so repeated capsaicin exposure produces a progressively smaller sensory response.
Capsaicin is a lipophilic vanillylamide with low water solubility; it is absorbed largely by passive diffusion in the upper small intestine and its uptake tracks the fat content of what it is taken with.
Absorbed capsaicinoids undergo extensive first-pass metabolism by hepatic cytochrome P450 enzymes, which is why systemic exposure after an oral dose is short-lived.
Where Capsaicin comes from.
Hot peppers are dried, extracted with a solvent, cleaned up, and then measured so the label can state how much of the pungent compound is in each dose. Some products use a lab-made version of the same class of molecule instead of a pepper extract.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Ripe fruit of pungent Capsicum species, grown for capsaicinoid content and dried after harvest.
Milled fruit is extracted with a food-grade solvent such as ethanol or a hydrocarbon, then the solvent is stripped to leave a capsicum oleoresin.
Pigments, waxes and non-pungent fractions are separated so the capsaicinoid content can be concentrated.
Assay by HPLC sets the declared capsaicinoid content, which is the number a dose is built from.
The standardised material is diluted in a carrier oil or adsorbed to a powder base and filled into capsules, often with a coating to shift release past the stomach.
Getting Capsaicin from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Pooled trials found capsaicin supplementation lowered fasting blood sugar modestly, while longer term markers of blood sugar control showed no clear change.Meta-analysis. Foshati et al., 2021 (Food & function). PMID 33998636 ↗
- Red pepper or capsaicin intake was associated with small improvements in blood lipid and blood pressure measures, with the certainty of the pooled evidence rated low.Meta-analysis. Ghoreishy et al., 2026 (Nutrition, metabolism, and cardiovascular diseases). PMID 41856833 ↗
- In healthy adults, capsaicinoid or capsinoid supplementation produced a small improvement in exercise performance measures, mainly in strength endurance tasks.Meta-analysis. Quizzini et al., 2026 (Nutrition research (New York, N.Y.)). PMID 41505853 ↗
- In adults with low HDL cholesterol, capsaicin supplementation raised HDL cholesterol and lowered several circulating markers compared with placebo.Randomised trial. Qin et al., 2017 (Nutrients). PMID 28930174 ↗
- A single dose of capsaicin before resistance training increased total repetitions completed in trained men compared with placebo.Randomised trial. Conrado de Freitas et al., 2018 (Journal of strength and conditioning research). PMID 28682933 ↗
- Acute capsaicin supplementation improved resistance exercise performance carried out after a high-intensity intermittent bout.Randomised trial. de Freitas MC et al., 2022 (Journal of Strength and Conditioning Research). PMID 31800470 ↗
- Acute capsaicin improved 1,500 m running time-trial performance and lowered rating of perceived exertion in the participants studied.Randomised trial. de Freitas MC et al., 2018 (Journal of Strength and Conditioning Research). PMID 29120986 ↗
- A double-blind study of capsaicin taken before high-intensity continuous exercise reporting the authors' performance findings for that protocol.Randomised trial. Padilha CS et al., 2020 (International Journal of Sports Medicine). PMID 32693427 ↗
- Acute phenylcapsaicin, a capsaicin analogue, improved CrossFit performance in a randomised, triple-blind, placebo-controlled design.Randomised trial. Triviño AR et al., 2026 (Journal of the International Society of Sports Nutrition). PMID 41536004 ↗
- Capsaicin was examined for muscle soreness and recovery markers after exercise-induced muscle damage in the players studied.Randomised trial. Rashki M et al., 2025 (Nutrients). PMID 40077683 ↗
- A systematic review and network meta-analysis of bioactive compounds for pain intensity and quality of life outcomes in which capsaicin is one of the named compounds.Meta-analysis. Tang R et al., 2025 (Frontiers in Pharmacology). PMID 41181607 ↗
- Capsaicin supplementation shifted the nutrigenomic signature linked to energy metabolism in adipose tissue in the animals studied.Animal study. Singh DP et al., 2026 (Naunyn-Schmiedeberg's Archives of Pharmacology). PMID 41171393 ↗
- In western-diet-fed animals, capsaicin supplementation was associated with lower circulating leptin and reduced markers of endoplasmic reticulum stress.Animal study. Kim HJ et al., 2023 (Food & Nutrition Research). PMID 38084147 ↗
- A pooled analysis of capsaicin supplementation trials in dairy cattle reporting lactational performance and haematological effects.Meta-analysis. Wasson DE et al., 2024 (Journal of Dairy Science). PMID 39307549 ↗
- Dietary capsaicin lessened jejunal injury in piglets given a lipopolysaccharide challenge.Animal study. Xie Z et al., 2026 (BMC Veterinary Research). PMID 41654850 ↗
- Dietary capsaicin was associated with better production performance and intestinal health measures in laying hens.Animal study. Zhang Y et al., 2025 (Animal Nutrition). PMID 40919308 ↗
- Dietary capsaicin around calving was associated with higher antioxidant capacity and immune measures in the cattle studied.Animal study. Li H et al., 2024 (Antioxidants). PMID 39857362 ↗
- Capsaicin supplementation influenced immunoglobulin measures relevant to passive immunity transfer in the animals studied.Animal study. Rodas ER et al., 2025 (Animals). PMID 40564229 ↗
- Dietary capsaicin was assessed for growth performance, blood profile and carcass and meat quality in finishing pigs.Animal study. Namted S et al., 2024 (Animal Bioscience). PMID 38754848 ↗
These are the studies our verdict leans on, chosen from the 2,787 we read for Capsaicin. The full linked list is below.
The studies, linked.
12 sources behind our Capsaicin verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialThe Use of QUTENZA™ in Standard Clinical Practice: a Phase IV, Multicentre, European Non-interventional StudyClinicalTrials.gov ↗429 participants · Completed
- Clinical trialA Non-interventional Post-registration Clinical Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic PainClinicalTrials.gov ↗319 participants · Completed
- Clinical trialStudy of Efficacy and Non-inferiority, With Two Capsaicin Topic Treatments, for the Moderate to Severe Pain in Diabetic Neuropathy.ClinicalTrials.gov ↗PHASE3 · 161 participants · Completed
- Clinical trialDelineating Physiologic Mechanisms of Swallowing Impairment and Decline in ALSClinicalTrials.gov ↗109 participants · Completed
- Clinical trialEfficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 0.0125% of Capsaicin to PlaceboClinicalTrials.gov ↗PHASE3 · 100 participants · Completed
- Clinical trialRandomized, Double Blind, Placebo Controlled Crossover Trial With Open Label Extension Of Topical 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin In The Treatment Of Pain Caused By Osteoarthritis Of The KneeClinicalTrials.gov ↗PHASE2 · 56 participants · Completed
- Clinical trialA Double-Blind, Randomized, Single-Centre, Placebo-Controlled, Crossover Study to Investigate the Effects of a Single Oral Dose of AZD1386 on Intradermal Capsaicin Evoked Pain Symptoms and Heat Sensitivity in Healthy VolunteersClinicalTrials.gov ↗PHASE1 · 36 participants · Completed
- Clinical trialEffect of Cannabidiol on Microglial Activation and Central Pain-SensitizationClinicalTrials.gov ↗EARLY PHASE1 · 28 participants · Completed
- Clinical trialA Pilot Study of the Effect of a Dietary Herbal Supplement Containing Capsaicin or Placebo on Satiety, Metabolic Rate and Food Intake in Healthy Adults.ClinicalTrials.gov ↗NA · 24 participants · Completed
- Clinical trialCough Desensitization Therapy for Cough Hypersensitivity Syndrome: Pilot 2ClinicalTrials.gov ↗PHASE1 · 22 participants · Completed
- Clinical trialTwo Part Study to Investigate Pharmacokinetics (PK) & Pharamcodynamics (PD) of SB-705498 in Cough. Part A:Open Label Study in Healthy Subjects to Determine Exposure to SB-705498. Part B:Double-blind, Placebo Controlled, Cross Over Study to Investigate Effect of SB-705498 on Capsaicin Induced Cough and 24 Hour Cough Counts in Cough PatientsClinicalTrials.gov ↗PHASE2 · 21 participants · Completed
- Clinical trialA Randomized, Controlled, Single-Blind Study to Investigate the Effect of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function In Healthy VolunteersClinicalTrials.gov ↗PHASE1 · 20 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 9,154 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Capsaicin is, not how risky it is. A report is not proof Capsaicin caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.